Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Medtronic May Be The Biggest Loser In The Tax Inversion Race After New Tax Rules By The US Treasury
Bidness Etc.
Wednesday, September 24, 2014 - 8:36am
tags:
Medtronic, tax inversions, M&A, Covidien, devices
Merrimack Does Well to License Marginal Cancer Drug to Baxter
TheStreet.com
Wednesday, September 24, 2014 - 8:30am
tags:
Merrimack Pharmaceuticals, MM-398, pancreatic cancer, Baxter International
AstraZeneca Posts Positive Data on its Type II Diabetes Drug
Yahoo/Zacks.com
Wednesday, September 24, 2014 - 8:00am
tags:
AstraZeneca, diabetes, Byetta, exenatide
Banned ImClone founder plans IPO for new venture
CNBC
Wednesday, September 24, 2014 - 7:56am
tags:
ImClone, Sam Waksal, IPOs, Kadmon
Pfizer explored takeover of rival Actavis
Marketwatch
Wednesday, September 24, 2014 - 7:54am
tags:
Pfizer, Actavis, tax inversions, M&A
Salix Receives $100 Million In Patent Infringement Settlement
Bidness Etc.
Tuesday, September 23, 2014 - 6:10pm
tags:
Salix, patents, Zegrid, Par Pharmaceutical, Santarus
Tax-deal crackdown's victims, say analysts? Mylan and Abbott, not Pfizer and AZ
Fierce Pharma
Tuesday, September 23, 2014 - 5:45pm
tags:
Mylan Labs, Pfizer, AstraZeneca, Shire, AbbVie, tax inversions, Abbott Labs
AdvaMed, PhRMA, BIO protest Sunshine law
Mass Device
Tuesday, September 23, 2014 - 5:43pm
tags:
AdvaMed, PhRMA, BIO, devices, physicial payments, Physician Payment Sunshine Act
Dealpolitik: Is Now the Time for Valeant to Make ‘Best and Final’ Offer?
WSJ Online
Tuesday, September 23, 2014 - 5:01pm
tags:
Allergan, Valeant Pharmaceuticals, M&A
Celgene Wins U.S. Approval of New Psoriasis Pill
Bloomberg
Tuesday, September 23, 2014 - 4:58pm
tags:
Celgene, psoriasis, FDA, Otezla
Pfizer Said to Approach Actavis to Gauge Interest in Deal
Bloomberg
Tuesday, September 23, 2014 - 4:56pm
tags:
Pfizer, Actavis, M&A
J&J’s Exit from Morcellator Sales Leaves Opportunities for Others
WSJ Online
Tuesday, September 23, 2014 - 4:54pm
tags:
JNJ, laparoscopic power morcellators
Pharma CEO: Why I Love Twitter
Brainstorm Digital
Tuesday, September 23, 2014 - 11:05am
tags:
Pharma CEOs, twitter, social media, IDEA Pharma
After New Drugs Delayed by DEA, Legislators Seek Overhaul of Drug Scheduling Process
RAPS.org
Tuesday, September 23, 2014 - 10:38am
tags:
DEA, FDA, drug approvals
Heads will roll at GlaxoSmithKline, investors say. The question is, whose?
Fierce Pharma
Tuesday, September 23, 2014 - 10:36am
tags:
GSK
Why the FTC Lawsuit over Pay-To-Delay Deals Matters: Carrier Explains
WSJ Pharmalot
Tuesday, September 23, 2014 - 10:33am
tags:
FTC, pay-for-delay
Ackman again threatens to sue Allergan over potential Salix deal
Yahoo/Reuters
Tuesday, September 23, 2014 - 10:02am
tags:
Bill Ackman, Allergan, Salix, M&A, Valeant Pharmaceuticals
U.S. Rule Targets Medtronic Tax-Free Use of Foreign Cash
Bloomberg
Tuesday, September 23, 2014 - 9:56am
tags:
Medtronic, tax inversions, devices
Who loses in biopharma as Treasury moves to block tax inversions?
Fierce Biotech
Tuesday, September 23, 2014 - 8:00am
tags:
tax inversions, Pfizer, Shire, AstraZeneca, AbbVie, Salix
Auxilium Rejects Endo‘s Offer, Still Plans To Merge With Canada-Based QLT Inc
Bidness Etc.
Tuesday, September 23, 2014 - 7:59am
tags:
Auxilium, Endo Health Solutions, QLT, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.